Samantha Semenkow
Stock Analyst at Citigroup
(3.25)
# 1,083
Out of 5,120 analysts
67
Total ratings
45.45%
Success rate
4.74%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Samantha Semenkow
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARGX argenx SE | Maintains: Buy | $1,124 → $1,091 | $835.68 | +30.55% | 8 | Jan 8, 2026 | |
| FOLD Amicus Therapeutics | Downgrades: Neutral | $17 → $15 | $14.29 | +1.47% | 2 | Dec 22, 2025 | |
| SYRE Spyre Therapeutics | Initiates: Buy | $64 | $32.75 | +95.42% | 1 | Dec 17, 2025 | |
| WVE Wave Life Sciences | Maintains: Buy | $16 → $30 | $13.43 | +123.38% | 2 | Dec 9, 2025 | |
| GPCR Structure Therapeutics | Maintains: Buy | $60 → $100 | $89.84 | +11.31% | 2 | Dec 9, 2025 | |
| NKTR Nektar Therapeutics | Initiates: Buy | $102 | $38.12 | +167.58% | 1 | Nov 26, 2025 | |
| AGIO Agios Pharmaceuticals | Initiates: Buy | $38 | $28.16 | +34.94% | 1 | Nov 26, 2025 | |
| RYTM Rhythm Pharmaceuticals | Initiates: Buy | $136 | $108.99 | +24.78% | 1 | Nov 25, 2025 | |
| BHVN Biohaven | Maintains: Buy | $28 → $14 | $11.75 | +19.15% | 2 | Nov 13, 2025 | |
| PRME Prime Medicine | Maintains: Neutral | $5 → $4.25 | $3.80 | +11.84% | 5 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $26 | $21.94 | +18.51% | 3 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $33 | $25.00 | +32.00% | 3 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $15 | $20.10 | -25.37% | 5 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $5 | $15.79 | -68.33% | 3 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $10 | $2.50 | +300.00% | 4 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $4 | $1.87 | +113.90% | 3 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $4.00 | +200.00% | 1 | Dec 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $15 | $4.59 | +226.80% | 2 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $80 | $9.16 | +773.36% | 2 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $14 | $3.51 | +298.86% | 6 | May 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $15 | $2.01 | +646.27% | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 → $50 | $26.08 | +91.72% | 3 | Sep 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $56 | $27.92 | +100.57% | 3 | Aug 9, 2023 |
argenx SE
Jan 8, 2026
Maintains: Buy
Price Target: $1,124 → $1,091
Current: $835.68
Upside: +30.55%
Amicus Therapeutics
Dec 22, 2025
Downgrades: Neutral
Price Target: $17 → $15
Current: $14.29
Upside: +1.47%
Spyre Therapeutics
Dec 17, 2025
Initiates: Buy
Price Target: $64
Current: $32.75
Upside: +95.42%
Wave Life Sciences
Dec 9, 2025
Maintains: Buy
Price Target: $16 → $30
Current: $13.43
Upside: +123.38%
Structure Therapeutics
Dec 9, 2025
Maintains: Buy
Price Target: $60 → $100
Current: $89.84
Upside: +11.31%
Nektar Therapeutics
Nov 26, 2025
Initiates: Buy
Price Target: $102
Current: $38.12
Upside: +167.58%
Agios Pharmaceuticals
Nov 26, 2025
Initiates: Buy
Price Target: $38
Current: $28.16
Upside: +34.94%
Rhythm Pharmaceuticals
Nov 25, 2025
Initiates: Buy
Price Target: $136
Current: $108.99
Upside: +24.78%
Biohaven
Nov 13, 2025
Maintains: Buy
Price Target: $28 → $14
Current: $11.75
Upside: +19.15%
Prime Medicine
Nov 11, 2025
Maintains: Neutral
Price Target: $5 → $4.25
Current: $3.80
Upside: +11.84%
Nov 11, 2025
Maintains: Buy
Price Target: $25 → $26
Current: $21.94
Upside: +18.51%
Nov 7, 2025
Maintains: Buy
Price Target: $31 → $33
Current: $25.00
Upside: +32.00%
Oct 29, 2025
Maintains: Buy
Price Target: $10 → $15
Current: $20.10
Upside: -25.37%
Oct 29, 2025
Downgrades: Sell
Price Target: $5
Current: $15.79
Upside: -68.33%
Aug 14, 2025
Maintains: Buy
Price Target: $13 → $10
Current: $2.50
Upside: +300.00%
May 15, 2025
Maintains: Buy
Price Target: $8 → $4
Current: $1.87
Upside: +113.90%
Dec 2, 2024
Initiates: Buy
Price Target: $12
Current: $4.00
Upside: +200.00%
Aug 9, 2024
Maintains: Buy
Price Target: $8 → $15
Current: $4.59
Upside: +226.80%
Jun 3, 2024
Reinstates: Buy
Price Target: $80
Current: $9.16
Upside: +773.36%
May 22, 2024
Maintains: Buy
Price Target: $10 → $14
Current: $3.51
Upside: +298.86%
May 9, 2024
Maintains: Buy
Price Target: $16 → $15
Current: $2.01
Upside: +646.27%
Sep 27, 2023
Maintains: Buy
Price Target: $33 → $50
Current: $26.08
Upside: +91.72%
Aug 9, 2023
Maintains: Buy
Price Target: $60 → $56
Current: $27.92
Upside: +100.57%